Lensar (LNSR) Asset Writedowns and Impairment (2020 - 2026)
Lensar (LNSR) reported Asset Writedowns and Impairment of $15000.0 for Q1 2026, down 25.0% year-over-year from $20000.0 in Q1 2025, and up 130.0% quarter-over-quarter from -$50000.0 in Q4 2025.
Lensar (LNSR) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Lensar (LNSR) has 7 years of Asset Writedowns and Impairment data on file, last reported at $15000.0 in Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at $15000.0, down 25.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5000.0 (down 100.13% YoY), and the FY2024 annual result was $43000.0, down 34.85% from the prior year.
- Asset Writedowns and Impairment advanced to $15000.0 in Q1 2026 per LNSR's latest filing, from -$50000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $3.7 million in Q2 2024 and troughed at -$50000.0 in Q4 2025.
- A 5-year average of $242125.0 and a median of $14000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment surged 28584.62% in 2024, then slumped 350.0% in 2025.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $25000.0 in 2022, then surged by 84.0% to $46000.0 in 2023, then tumbled by 56.52% to $20000.0 in 2024, then tumbled by 350.0% to -$50000.0 in 2025, then soared by 130.0% to $15000.0 in 2026.
- Business Quant data shows LNSR's Asset Writedowns and Impairment at $15000.0 in Q1 2026, -$50000.0 in Q4 2025, and -$7000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | -50,000.00 |
| Dec 31, 2025 | -50,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Jun 30, 2024 | 3.73 Mn |
| Jun 30, 2024 | 3.73 Mn |
| Mar 31, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Sep 30, 2023 | -6,000.00 |